Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 November 2025 | Viewed by 1542
Special Issue Editors
Interests: pharmacovigilance; drug safety; adverse drug reactions
Interests: design of bioactive compounds; chemical synthesis; biological evaluation; compounds with medicinal and pharmaceutical interests
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The evolution of pharmacovigilance is increasingly challenged by phenomena such as drug misuse, off-label use and medication errors, all of which can be linked to underlying pharmacological mechanisms. These issues not only pose a significant risk to patient safety but also emphasise the importance of understanding how pharmacodynamic and pharmacokinetic factors contribute to adverse drug reactions (ADRs) and treatment failures. This Special Issue, entitled “Insights into Pharmacovigilance: Addressing Drug Misuse and Enhancing Drug Safety”, seeks contributions that explore the pharmacological basis of drug safety issues and propose mechanism-based approaches to improve pharmacovigilance systems. We invite original research articles and systematic reviews that go beyond observational data to investigate molecular targets, receptor interactions, metabolic pathways, drug–drug interactions or genetic polymorphisms that may affect drug safety.By linking pharmacological insights with regulatory and clinical perspectives, this Special Issue aims to provide a science-based framework for the optimisation of post-market surveillance and the advancement of drug safety science.
Dr. Cristina Sofia De Jesus Monteiro
Dr. Samuel Martins Silvestre
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reaction
- pharmacovigilance
- drug safety
- signal detection
- risk management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
